BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7920173)

  • 1. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
    Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D; Riccioni R; Mandelli F; Lo Coco F
    Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z; Chen SJ; Wang ZY
    C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP
    Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of translocation t(15;17) on the gene expression regulation of myeloblastin during all trans retinoic acid induced myeloid differentiation in human leukemic cells].
    Ballerini P; Besançon F; Cayre YE
    C R Seances Soc Biol Fil; 1995; 189(4):521-30. PubMed ID: 8564566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular study on the distinct isoforms of PML-RAR alpha fusion gene transcripts in acute promyelocytic leukemia].
    Geng JP
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):197-200, 252. PubMed ID: 8395310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
    Nervi C; Poindexter EC; Grignani F; Pandolfi PP; Lo Coco F; Avvisati G; Pelicci PG; Jetten AM
    Cancer Res; 1992 Jul; 52(13):3687-92. PubMed ID: 1319828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
    Chen Z; Wang W; Pan J; Chen L; Xue Y
    Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The APL-associated fusion proteins.
    Minucci S; Cioce M; Maccarana M; Pelicci PG
    Haematologica; 1999 Jun; 84 Suppl EHA-4():70-1. PubMed ID: 10907473
    [No Abstract]   [Full Text] [Related]  

  • 19. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.